Committed to Your Prostate Health Education
Garrett D. Pohlman, MD
Prostate Health Education in a Podcast!
So the big question is this: how can men and those who care for them better educate themselves regarding prostate health, the conditions that affect the prostate, and the latest technology in managing these conditions? That is the question and this podcast will provide the answers. My name is Garrett D. Pohlman, MD, founder and host of The Prostate Health Podcast. On a weekly basis I will be chatting with experts, innovators, and leaders in the field of Urology – sharing useful information with the general public to improve their lives and increase their overall health.
Get Dr. Pohlman’s FREE Guide – What to Expect From
Your First Urology Appointment
96: Advancing Precision Medicine: EpiSwitch PSE Prostate Cancer Screening Test with 94% Accuracy – Robert Heaton, MD
Did you know that prostate cancer is the second most prevalent cancer in American men, following skin cancer? A new diagnosis of prostate cancer occurs every two minutes.
We are delighted to partner with Oxford Biodynamics for today’s episode with Dr. Robert Heaton, who joins us to discuss a ground-breaking new prostate cancer screening test that predicts the risk of prostate cancer with 94% accuracy, using a simple blood test.
Dr. Heaton is a board-certified pathologist. He completed his medical training at Georgetown University and then spent the next twenty years in the US Navy. After finishing his residency training in pathology, Dr. Heaton became the Director of Laboratory and Clinical Support Services for the National Naval Medical Center before joining various hospital pathology labs and life sciences companies. He is currently the Laboratory Medical Director for Oxford Biodynamics at their CLIA-certified clinical lab in Maryland, where he oversees the clinical operations of their liquid biopsy blood tests.
In today’s episode, we dive into the details of the innovative EpiSwitch Prostate Screening test, known as the PSE, designed to confirm the presence of prostate cancer, whether symptoms are present or not. This technological advancement is a game-changer! It empowers urologists by providing a precise tool to assess whether a patient should undergo a biopsy or opt for continued monitoring.
Stay tuned to learn how this simple yet powerful tool streamlines the screening process for men struggling with prostate cancer.
95: Initial Experience with the In-Office Promaxo MRI System: Identifying and Targeting Prostate Cancer
Within the ever-evolving landscape of medical technology, breakthrough innovations continuously emerge to revolutionize how urologists approach the detection and treatment of prostate cancer.
In this episode, we dive into Dr. Pohlman’s first-hand encounter with the state-of-the-art Promaxo MRI system that has transformed his practice since June.
On the patient side, we unravel the inner workings of the Promaxo MRI technology, explaining how the system benefits men going through a prostate biopsy. For urologists listening, we explore the practicalities of how Dr. Pohlman integrated the Promaxo MRI system into an office setting, covering the minimal facility prerequisites and describing how the system synced with the general workflow of his clinic. We also get into how Dr. Pohlman is gearing up to begin using the Promaxo MRI system for performing in-office targeted focal ablation for prostate cancer and we also share crucial considerations for urologists to bear in mind when performing low-field MRIs on patients with implants.
Stay tuned for a transformative journey through the world of cutting-edge medical technology!
94: Targeted Focal Laser Ablation for Prostate Cancer – Michael Magnani
We are delighted to team up with Clinical Laserthermia Systems Americas this week for a groundbreaking episode where we dive into the world of cutting-edge medical technology and shed light on an emerging innovation that promises to revolutionize the management of prostate cancer!
CLS is a leading medical device company at the forefront of pioneering precise and effective interventional healthcare solutions. They have developed an innovative CLS thermal therapy system for image-guided focal laser ablation that spares healthy tissue while minimizing the debilitating side effects often associated with traditional treatments. This technology can even be administered by a urologist in an office setting, bringing hope and convenience to countless patients.
We are honored to have Michael Magnani, the President of CLS, joining us today to explore their new thermal therapy system for image-guided focal laser ablation. With a career spanning over two decades in corporate management within the life sciences industry, he brings a wealth of expertise in product development, corporate strategy, business development, and commercialization. He graduated from the unique Biomedical Enterprise Program at the MIT Sloan School of Management and holds a Bachelor of Science in Microbiology from the University of California, San Diego.
Join us to learn about the exciting possibilities this transformative new technology holds for the future of prostate cancer management!
The Grand Rounds in Urology™ (GRU) Community is a premier network for urologists, medical oncologists, radiation oncologists, and other healthcare providers to keep up-to-date with best practices and current clinical updates for the treatment of urologic diseases and conditions, especially genitourinary cancers. GRU provides dissemination of knowledge through online content, live meetings, lectures, conversations, information sharing, and constructive debates, ultimately improving physician performance and patient outcomes throughout the world.
Prostate Conditions Education Council (PCEC) is a national non-profit dedicated to spreading awareness about prostate health through early detection and research. As the leading innovative organization, saving and improving the lives of men and their loved ones, PCEC sets the pace in early detection, research, education and awareness for prostate cancer and all prostate conditions.
As the prostate cancer landscape has evolved, so have we. Today, we are the destination for taking action to end prostate cancer and making prostate cancer research a national priority. With a new name, ZERO – The End of Prostate Cancer, we are still on the front lines in Washington, DC and grassroots communities to provide much-needed programs that positively impact the lives of both men at risk and men suffering from this disease. We’re providing men and families with educational resources and funding promising research for improved early detection options. Our mantra to support, educate, and activate is mobilizing a like-minded, passionate, and multigenerational army of advocates across the country to end prostate cancer.
Whether you are a 40-year-old father of three young children in the prime of your life or a 65-year-old excited to enjoy your retirement and spend time with your grandchildren, the face of prostate cancer can look very different. What unites us all is our steadfast commitment to eliminate the pain and suffering and create Generation ZERO – the first generation of men free from prostate cancer.
I may earn a commission from the sponsors listed on this website. By clicking a link, I may earn a small commission. You can read the full disclosure here.
Better Prostate Education is our Mission!
Subscribe to the show on any of these podcast apps